Your browser doesn't support javascript.
loading
An AAV vaccine targeting the RBD of the SARS-CoV-2 S protein induces effective neutralizing antibody titers in mice and canines.
Liu, Fei; Feng, Canbin; Xu, Shiqi; Wu, Qiang; Tang, Jian; Chen, Yan; Xu, Ruisheng; Chen, Fuliang; Gao, Ni; Xu, Zhengzheng; Gu, Shihui; Lan, Yang; Zhou, Haibo; Hu, Xinde; Wang, Xiaojing.
Afiliación
  • Liu F; Anhui Province Key Laboratory of Clinical and Preclinical Research in Respiratory Disease, Molecular Diagnosis Center, Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital, Bengbu Medical College, No. 287 Changhuai Road, Bengbu, Anhui, China; College of Life Sciences, Univer
  • Feng C; Laboratory of Genome Editing and Brain Diseases, Center for Excellence in Brain Science and Intelligence Technology/Institute of Neuroscience, Chinese Academy of Science, Shanghai 200031, China.
  • Xu S; CAS Key Laboratory of Molecular Virology & Immunology, Institute Pasteur of Shanghai, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China.
  • Wu Q; Laboratory of Genome Editing and Brain Diseases, Center for Excellence in Brain Science and Intelligence Technology/Institute of Neuroscience, Chinese Academy of Science, Shanghai 200031, China; College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, China.
  • Tang J; State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, China.
  • Chen Y; Laboratory of Genome Editing and Brain Diseases, Center for Excellence in Brain Science and Intelligence Technology/Institute of Neuroscience, Chinese Academy of Science, Shanghai 200031, China.
  • Xu R; Laboratory of Genome Editing and Brain Diseases, Center for Excellence in Brain Science and Intelligence Technology/Institute of Neuroscience, Chinese Academy of Science, Shanghai 200031, China.
  • Chen F; Anhui Province Key Laboratory of Clinical and Preclinical Research in Respiratory Disease, Molecular Diagnosis Center, Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital, Bengbu Medical College, No. 287 Changhuai Road, Bengbu, Anhui, China.
  • Gao N; Laboratory of Genome Editing and Brain Diseases, Center for Excellence in Brain Science and Intelligence Technology/Institute of Neuroscience, Chinese Academy of Science, Shanghai 200031, China; College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, China.
  • Xu Z; Laboratory of Genome Editing and Brain Diseases, Center for Excellence in Brain Science and Intelligence Technology/Institute of Neuroscience, Chinese Academy of Science, Shanghai 200031, China.
  • Gu S; Department of Hand Surgery, Huashan Hospital, Fudan University, Shanghai, China.
  • Lan Y; Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Zhou H; Laboratory of Genome Editing and Brain Diseases, Center for Excellence in Brain Science and Intelligence Technology/Institute of Neuroscience, Chinese Academy of Science, Shanghai 200031, China.
  • Hu X; Laboratory of Genome Editing and Brain Diseases, Center for Excellence in Brain Science and Intelligence Technology/Institute of Neuroscience, Chinese Academy of Science, Shanghai 200031, China. Electronic address: huxinde@ion.ac.cn.
  • Wang X; Anhui Province Key Laboratory of Clinical and Preclinical Research in Respiratory Disease, Molecular Diagnosis Center, Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital, Bengbu Medical College, No. 287 Changhuai Road, Bengbu, Anhui, China. Electronic address: wangxiaojing
Vaccine ; 40(9): 1208-1212, 2022 02 23.
Article en En | MEDLINE | ID: mdl-35094871
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas Virales / COVID-19 Límite: Animals / Humans Idioma: En Revista: Vaccine Año: 2022 Tipo del documento: Article Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas Virales / COVID-19 Límite: Animals / Humans Idioma: En Revista: Vaccine Año: 2022 Tipo del documento: Article Pais de publicación: Países Bajos